IP Library Granted Patent US 10,010,328
Granted Patent B2
US 10,010,328 · App. 14/880,126 · Granted Jul 3, 2018

Endovascular occlusion device with hemodynamically enhanced sealing and anchoring

Inventors: Andrew H. Cragg (Edina, MN); John Logan (Plymouth, MN); Brett E. Naglreiter (Hollywood, FL); Alejandro Espinosa (Miami, FL)
Assignee: NeuVT Limited
A61B17/12172A61B17/12031A61B17/12036A61B17/12109A61B17/12177A61B2017/00526A61B2017/12054A61B2017/22082
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,010,328
App. No.
14/880,126
Granted
Jul 3, 2018
Kind
B2
Abstract

A vascular occlusion device having an expandable frame that carries a membrane. The membrane can include a tubular portion configured to transition between an open configuration in which the tubular portion is configured to receive a guidewire and a closed configuration in which the tubular portion is configured to occlude blood flow.

Claims (32)

1. A vascular occlusion device, comprising:

an expandable frame comprising an upstream lobe and a downstream lobe separated by a neck portion, the upstream lobe comprising a concave configuration which is concave in a direction away from the downstream lobe, the neck portion forming a guidewire opening; and

a membrane carried by at least the upstream lobe, the membrane comprising a tubular portion extending in an upstream direction and at least partially through the upstream lobe, the tubular portion comprising a lumen at least partially aligned with the guidewire opening,

wherein the tubular portion comprises an reinforced portion anchored with respect to the expandable frame and a free portion extending in the upstream direction, a wall thickness of the reinforced portion being at least 3× greater than a wall thickness of the free portion,

wherein the tubular portion is tapered in the upstream direction and across at least a majority of a length of the tubular portion,

wherein the tubular portion extends in the upstream direction prior to deployment and post-deployment, and

wherein the tubular portion is configured to transition between an open configuration in which the tubular portion is configured to receive a guidewire and a closed configuration in which the tubular portion is configured to occlude blood flow.

2. The vascular occlusion device of claim 1 , wherein the tubular portion is integrally formed with a remaining portion of the membrane.

3. The vascular occlusion device of claim 1 , wherein the reinforced portion is integrally formed with the free end portion.

4. The vascular occlusion device of claim 1 , wherein the free portion comprises a duckbill valve.

5. The vascular occlusion device of claim 1 , wherein the tubular portion is tapered at an angle of less than about five degrees.

6. The vascular occlusion device of claim 1 , wherein the reinforced portion is non-porous and the free portion is porous.

7. The vascular occlusion device of claim 1 , wherein a wall density of the reinforced portion is at least 10× greater than a wall density of the free portion.

8. The vascular occlusion device of claim 1 , wherein the tubular portion extends outward of an open end of the upstream lobe.

9. The vascular occlusion device of claim 1 , wherein a ratio between a length of the tubular portion and a length of the upstream lobe is at least about 1:2.

10. The vascular occlusion device of claim 1 , wherein a transition between the wall thickness of the reinforced portion and the wall thickness of the free portion is a stepped transition.

11. The vascular occlusion device of claim 1 , wherein the reinforced portion extends across about 50% to about 75% of a length of the tubular portion.

12. The vascular occlusion device of claim 1 , wherein the reinforced portion extends across about 50% to about 75% of a length of the tubular portion.

13. A vascular occlusion device, comprising:

an expandable frame comprising a concave portion that is concave in an upstream direction, the expandable frame comprising a guidewire opening; and

a membrane carried by at least concave portion, the membrane comprising a tubular portion extending in the upstream direction and at least partially through the concave portion, the tubular portion comprising a lumen at least partially aligned with the guidewire opening,

wherein the tubular portion comprises an reinforced portion anchored with respect to the expandable frame and a free portion extending in the upstream direction, a wall thickness of the reinforced portion being at least 3× greater than a wall thickness of the free portion,

wherein the tubular portion is tapered in the upstream direction and across at least a majority of a length of the tubular portion,

wherein the tubular portion extends in the upstream direction prior to deployment and post-deployment, and

wherein the tubular portion is configured to transition between an open configuration in which the tubular portion is configured to receive a guidewire and a closed configuration in which the tubular portion is configured to occlude blood flow.

14. The vascular occlusion device of claim 13 , wherein the tubular portion is integrally formed with a remaining portion of the membrane.

15. The vascular occlusion device of claim 13 , wherein the reinforced portion is integrally formed with the free end portion.

16. The vascular occlusion device of claim 13 , wherein the free portion comprises a duckbill valve.

17. The vascular occlusion device of claim 13 , wherein the tubular portion is tapered at an angle of less than about 5 degrees.

18. The vascular occlusion device of claim 13 , wherein the reinforced portion is non-porous and the free portion is porous.

19. The vascular occlusion device of claim 13 , wherein a wall density of the reinforced portion is at least 10× greater than a wall density of the free portion.

20. The vascular occlusion device of claim 13 , wherein a transition between the wall thickness of the reinforced portion and the wall thickness of the free portion is a stepped transition.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2019
From: NEUVT LIMITED
To: EMBOLIC ACCELERATION, LLC
Reel/Frame 050417/0232 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2018
From: EMBA MEDICAL LIMITED
To: NEUVT LIMITED
Reel/Frame 045461/0492 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2018
From: CRAGG, ANDREW H.; LOGAN, JOHN; NAGLREITER, BRETT E.; ESPINOSA, ALEJANDRO
To: EMBA MEDICAL LIMITED
Reel/Frame 045194/0505 →
Continuity (6)
Continuation In Part 14661579 · Mar 18, 2015
Continuation 14449037 · Jul 31, 2014
Provisional Application 61975631 · Apr 4, 2014
Provisional Application 61936801 · Feb 6, 2014
Provisional Application 61860856 · Jul 31, 2013
Related Publication 20160030052A1 · Feb 4, 2016
Cited By (2)
US 12,256,935 US 12,661,124